Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal Timing of Intravesical GAG Restoration Therapy for BCG-Induced Bladder Toxicity in Patients With Non-Muscle-Invasive Bladder Cancer: A Prospective Randomized Study

NCT07495072 is registered in ClinicalTrials.gov with BLAD-HYA Group as lead sponsor.

NCT NCT07495072
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07495072 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal Timing of Intravesical GAG Restoration Therapy for BCG-Induced Bladder Toxicity in Patients With Non-Muscle-Invasive Bladder Cancer: A Prospective Randomized Study
Lead sponsor
BLAD-HYA Group
Phase
Not applicable
Overall status
Recruiting
Start date
November 3, 2025
Completion date
June 30, 2027
Enrollment
56 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bcg-induced cystitis, urinary bladder neoplasms